Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data / Ferté, C; Koscielny, S; Albiges, L; Rocher, L; Soria, Jc; Iacovelli, Roberto; Loriot, Y; Fizazi, K; Escudier, B.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - (2013). [10.1016/j.eururo.2013.08.010]
Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data.
IACOVELLI, ROBERTO;
2013
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
